- Payment of outstanding purchase consideration to the promoter for the spin-off of the API businessb)
- Funding capital expenditure requirements
- General corporate purposes
Fresh Issue of 1,47,22,222 Shares Rs.720 = Rs.1,060.00 Crores
Offer for Sale of 63,00,000 Shares Rs.720 = Rs.453.60 Crores
Equity Shares outstanding after the Issue = 12,25,27,172 Shares
Category-wise Break up:
Anchor: 63,06,667 Shares = 454.08 Crores
QIB: 42,04,444 Shares = 302.72 Crores
NII: 31,53,333 Shares = 227.04 Crores
RII: 73,57,778 Shares = 529.76 Crores (Lot size: 20 = 3,67,889 Forms)
Total Issue: 2,10,22,222 Shares = 1513.60 Crores
Subscription Required for 1X
RII: 3,67,889 Forms
NII: 227.04 Crores
Financial Information (Basis of Valuation)
The information is collated from the following documents:
1) RHP = Red Herring Prospectus Dated July 19, 2021 (358 pages)
EPS for FY18-19 >>> Rs.24.64 (Page #82 of RHP)
EPS for FY19-20 >>> Rs.29.04 (Page #82 of RHP)
EPS for FY20-21 >>> Rs.32.61 (Page #82 of RHP)
RoNW for FY18-19 >>> 99.25% (Page #83 of RHP)
RoNW for FY19-20 >>> 77.94% (Page #83 of RHP)
RoNW for FY20-21 >>> 46.71% (Page #83 of RHP)
NAV as on March 31, 2021 was Rs.69.82 (Page #83 of RHP)
Listed Industry Peer Group:
- Divis Laboratories
- Laurus Labs
- Shilpa Medicare
- Aarti Drugs
- Solara Active Pharma Sciences
Glenmark Life Sciences IPO Review
- Apply for Listing Gain and Long Term Gain
Brokerage Firm IPO Reviews
- Axis Capital: Neutral
- Choice Equity: Apply
- GEPL Capital: Apply
- Anand Rathi: Apply
- ICICI Direct: Apply
- Angel Broking: Apply
Glenmark Life Sciences IPO Date & Price Band
| IPO Open: | 27 July 2021 |
| IPO Close: | 29 July 2021 |
| IPO Size: | Approx ₹1514 Crores |
| Fresh Issue: | Approx ₹1060 Crores |
| Offer for Sale: | Approx ₹454 Crores, 63,00,000 Shares |
| Face Value: | ₹2 Per Equity Share |
| Price Band: | ₹695 to ₹720 Per Share |
| Listing on: | BSE & NSE |
| Retail Portion: | 35% |
| Equity: | – Shares |
Glenmark Life Sciences IPO Market Lot
| Minimum Lot Size: | Minimum 20 Shares |
| Minimum Amount: | ₹14,400 |
| Maximum Lot Size: | Maximum 260 Shares |
| Maximum Amount: | ₹187,200 |
Glenmark Life Sciences IPO Date, Time Table, Allotment & Listing
| Basis of Allotment: | 27 July 2021 |
| Basis of Allotment: | 29 July 2021 |
| Basis of Allotment: | 03 August 2021 |
| Refunds: | 04 August 2021 |
| Credit to Demat Account: | 05 August 2021 |
| Listing Date: | 06 August 2021 |
Glenmark Life Sciences IPO Form
How to apply the Glenmark Life Sciences IPO? You can apply Glenmark Life Sciences IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Glenmark Life Sciences IPO in the Invest section. The other option you can apply Glenmark Life Sciences IPO via IPO forms download via NSE and BSE. Check out the Glenmark Life Sciences forms – click NSE Forms & BSE Forms blank IPO forms download, fill and submit in your bank or with your broker.
Glenmark Life Sciences Company Financial Report
| ₹ in Crores | |||||
| Revenue | Expenses | PAT | |||
| 2018 | ₹0.25 | ₹0.26 | -₹0.43 | ||
| 2019 | ₹886.87 | ₹658.59 | ₹195.59 | ||
| 2020 | ₹1549.30 | ₹1128.24 | ₹313.10 | ||
| 2021 9M | ₹1418.47 | ₹1088.15 | ₹246.90 | ||
Company Promoters
- Glenmark Pharmaceuticals Limited
About Glenmark Life Sciences
We are in the business of making high-quality drugs by unlocking the possibilities of science. Over the years, we have established strong relationships with leading global generic pharmaceutical companies that have helped us expand our product offerings and geographic reach. We work with 16 of the 20 largest generic companies globally. (Source: A Year of Surprises Shakes Up Off-Patent Industry” | Informa, 2020)
With 120 APIs in our catalogue, we are blending innovation and operational excellence to deliver on the promise of service, reliability, and consistent product quality.
Powered by our massive, world-class manufacturing and research capabilities, we supply high-quality APIs to more than 540 pharma companies in multiple countries.
Quick Links
DRHP Draft Prospectus
RHP Draft Prospectus
Glenmark Life Sciences IPO Subscription Numbers
Glenmark Life Sciences IPO Registrar
KFin Technologies Private Limited (Formerly known as
Karvy Fintech Private Limited)
Selenium Tower-B
Plot No-31 and 32, Financial District
Nanakramguda, Serilingampally
Hyderabad, Rangareddi 500032
Telangana, India
Tel: +91 40 6716 2222
E-mail: [email protected]
Investor Grievance E-mail: [email protected]
Website: www.kfintech.com
Contact Person: M Murali Krishna
SEBI Registration No.: INR000000221
Glenmark Life Sciences IPO Lead Managers
- Kotak Mahindra Capital Company Limited
- BofA Securities India Limited
- Goldman Sachs (India) Securities Private Limited
- DAM Capital Advisors Limited
- BOB Capital Markets Limited
- SBI Capital Markets Limited
Company Address
Glenmark Life Sciences Limited
Registered Office:
Plot No. 170-172, Chandramouli Industrial Estate,
Mohol Bazarpeth, Solapur 413 213, Maharashtra
Corporate Office:
Glenmark House, B. D. Sawant Marg,
Andheri (East), Mumbai 400099,
Maharashtra, India
Tel: +912189 234456/ +912189 234246
Website: www.glenmarklifesciences.com
Contact Person: Rudalf Corriea
(Company Secretary and Compliance Officer)
E-mail: [email protected]
Corporate Identity Number: U74900PN2011PLC139963
Glenmark Life Sciences IPO FAQs
What is Glenmark Life Sciences IPO?
When Glenmark Life Sciences IPO will open?
What is Glenmark Life Sciences IPO Investors Portion?
How to Apply the Glenmark Life Sciences IPO?
How to Apply the Glenmark Life Sciences IPO through Zerodha?
How to Apply the Glenmark Life Sciences IPO through Upstox?
What is Glenmark Life Sciences IPO Size?
What is Glenmark Life Sciences IPO Price Band?
What is Glenmark Life Sciences IPO Minimum and Maximum Lot Size?
What is Glenmark Life Sciences IPO Allotment Date?
What is Glenmark Life Sciences IPO Listing Date?
Note: The Glenmark Life Sciences IPO details added as it is officially announced. The IPO grey market premium (Glenmark Life Sciences IPO Premium) started. You can check our IPO grey market page for daily updates.)
